The Digital Intervention

Lupus Foundation of America Research Accomplishments to be Presented at the 2023 American College of Rheumatology Annual Meeting

Retrieved on: 
Tuesday, November 7, 2023
SLE, Rheumatology, Patient, Lupus Foundation of America, American College, RAY, Social media, Burden, CLE, Fatigue, Medicine, History, Racism, Language, Human, Observational study, Mental health, RN, Lupus, Doctor of Philosophy, News, MBBS, Social, HES, The Digital Intervention, Quality of life, Education, LFA, American Indians, Lead, Alaska Natives, Skin, Delphi, SELF, Communication, Monash University, Pharmaceutical industry, Nursing, Research, Diagnosis

WASHINGTON, Nov. 7, 2023 /PRNewswire/ -- The American College of Rheumatology Convergence 2023 meeting will be held in San Diego, CA from November 10-15, 2023.

Key Points: 
  • WASHINGTON, Nov. 7, 2023 /PRNewswire/ -- The American College of Rheumatology Convergence 2023 meeting will be held in San Diego, CA from November 10-15, 2023.
  • "As exploration and understanding of lupus grows, the Lupus Foundation of America continues to lead, contribute and support many novel and exciting investigations that propel the field forward," said Joy Buie, PhD, MSCR, RN, Director of Research, Lupus Foundation of America.
  • Throughout the ACR Meeting, the Lupus Foundation of America will share updates on social media highlighting the innovative scientific initiatives and research studies presented, as well as breaking news.
  • Follow the Lupus Foundation of America for evolving conference hot topics and research highlights at LFA's Twitter , Facebook , LinkedIn .

ENOSIS THERAPEUTICS AND OVID CLINICS ANNOUNCE PARTNERSHIP TO LAUNCH WORLD'S FIRST IN-CLINIC APPLICATION OF VIRTUAL REALITY MODULATED PSYCHEDELIC-AUGMENTED PSYCHOTHERAPY

Retrieved on: 
Monday, October 31, 2022
Leadership, APT, The MINDS Foundation, Therapy, Physician, Research, Partnership, Swinburne University of Technology, Curriculum, Patient, Mental health, Minds, Industry, The Digital Intervention, Entrepreneurship, Virtual reality, VR, Technology, Atypical, Protocol, Psychotherapy, MIND, Pharmaceutical industry, Medical imaging, Medicine, Enosis

MELBOURNE, Australia, Oct. 31, 2022 /PRNewswire/ -- Enosis Therapeutics, (or 'Enosis'), a medical technology and psychedelic research company that leverages virtual reality (VR) for the contextual modulation of psychedelic therapy to improve treatment outcomes, has partnered with OVID Clinics and the MIND Foundation to implement the world's first in-clinic application of VR with Psychedelic-Assisted therapy. The Berlin-based healthcare services provider that delivers integration-focused and psychedelic-based psychotherapies through its network of clinics, "OVID Clinics", has begun offering its patients the opportunity to receive psychedelic-assisted psychotherapy integrated with Enosis' science-backed virtual technology protocols.

Key Points: 
  • The Berlin-based healthcare services provider that delivers integration-focused and psychedelic-based psychotherapies through its network of clinics, "OVID Clinics", has begun offering its patients the opportunity to receive psychedelic-assisted psychotherapy integrated with Enosis' science-backed virtual technology protocols.
  • The positive results from this first study have led Enosis' to begin offering VR scenarios with psychedelic-assisted therapy inside OVID Clinics.
  • "The Enosis team is honored to partner with OVID Clinics and the MIND Foundation to commence the first in-clinic application of our VR protocols as an adjunct to psychedelic-assisted psychotherapy," said Agnieszka D. Sekula, Co-Founder of Enosis Therapeutics.
  • "At OVID Clinics, we believe in a personalized, evidence-based, medical & psychotherapeutic approach tailored to the patients' needs.

PAU Launches the Technology and Mental Health Concentration within its MS in Psychology Degree

Retrieved on: 
Friday, June 3, 2022
Science, PAU, Student, Multimedia, Mental health, Behavior, Virtual reality, The Digital Intervention, UX, Palo Alto University, Digital, Screen time, Technology, Psychology, PALO, Master of Science, Digital world, User experience, Medicine

PALO ALTO, Calif., June 3, 2022 /PRNewswire-PRWeb/ -- Starting in the fall of 2022, the Master of Science in Psychology program at Palo Alto University (PAU) will offer a Technology and Mental Health Concentration. This concentration will explore the important role technology plays in today's society, the negative and positive effects of technology on mental health, and the complexity of the interaction between technology and human behavior.

Key Points: 
  • PALO ALTO, Calif., June 3, 2022 /PRNewswire-PRWeb/ -- Starting in the fall of 2022, the Master of Science in Psychology program at Palo Alto University (PAU) will offer a Technology and Mental Health Concentration .
  • This concentration will explore the important role technology plays in today's society, the negative and positive effects of technology on mental health, and the complexity of the interaction between technology and human behavior.
  • Utilizing technology to enhance mental health is an emerging area of study, and PAU is at the forefront of this burgeoning field.
  • The Technology and Mental Health Concentration covers current trends in mental health and wellness and includes these courses:
    1) Technology and Mental Health for Children and Adolescents: Screen Time, Digital Interventions, and Teletherapy.